Rapt Market Share Analysis for May 2026

RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases. Our cutting-edge science is fully focused on developing therapeutics that intelligently target key drivers of the immune system to transform the treatment of inflammatory and immunologic diseases, and improve and empower countless lives. Join us in our quest.

Health > Biotechnology and Pharmaceuticals

Domainrapt.com

Year Founded2015

Employees51 - 200

Annual Revenue$2M - $5M

Rapt

Rapt (including company regionals)

rapt.com

See more website traffic and engagement information

Rapt Revenue up to May 2026 is 2M - 5M

revenue generated by Rapt top domains

Rapt top domains revenue over 3 years

Revenue for Rapt top domains

rapt.com2M - 5M

See more with Sales Intelligence

Total visits to Rapt's top domains

Understand Rapt market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rapt.com6K

See more with Sales Intelligence

Avg. visit duration in Rapt's top domains

Analyze Rapt engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

rapt.com00:00:02

See more with Sales Intelligence

Avg. pageviews on Rapt's top domains

See how Rapt keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rapt.com1.31

See more with Sales Intelligence

Rapt top competitors by domain

Top similar sites in May 2026, ranked by their affinity

gsk.comCompany NameGSK plcEmployees> 10001HQUnited Kingdom, LondonAnnual revenue> $1BTotal visits969.3KHealth > Health - Other

Top technologies used by Rapt

These are the website technologies, by industry, used by Rapt top domains

Advertising (4)

DoubleClick

Widget (3)

Twemoji

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

More Technologies

6

See all

News & Signals from Rapt

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRAPT Therapeutics, Inc. is developing novel therapies for patients living with inflammatory and immunologic diseases.GSK announced that it has entered a definitive agreement to acquire RAPT Therapeutics, a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunologic diseases.

NewsGlaxoSmithKline is planning to acquire RAPT Therapeutics, Inc. for $2.2B.British pharmaceutical company GSK has signed a definitive agreement to acquire US biotech company Rapt Therapeutics for USD 58 per share, representing a total value of USD 2.2bn, announces GSK on Tuesday before the market opened.

NewsRAPT Therapeutics, Inc. attends event 44th Annual J.P. Morgan Healthcare Conference.SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) - RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific Time.